Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Walmart, Home Depot Rise Premarket; Tesla, Pfizer Fall

Published 11/16/2021, 07:55 AM
Updated 11/16/2021, 07:55 AM
© Reuters

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Tuesday, November 16th. Please refresh for updates.

  • Walmart (NYSE:WMT) stock rose 0.7% after the retail giant raised its annual sales and profit forecasts, expecting strong demand during the crucial holiday season.

  • Tesla (NASDAQ:TSLA) stock fell 1.1% after CEO Elon Musk sold more shares of the electric vehicle maker a day earlier, while JPMorgan Chase brought a $162-million lawsuit against the company alleging breach of contract over stock warrants that came due this year.

  • Home Depot (NYSE:HD) stock rose 0.8% after the retailer easily beat quarterly sales estimates, buoyed by a strong housing market that kept home improvement spending strong.

  • Pfizer (NYSE:PFE) stock fell 0.9% after the drugmaker said it will allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low- and middle-income countries.

  • Microsoft (NASDAQ:MSFT) stock rose 0.2% after Credit Suisse initiated coverage of the software giant at ‘outperform’, seeing significant growth ahead and another 19% stock price gain.

  • Southwest Airlines (NYSE:LUV) stock fell 0.9% after Goldman Sachs downgraded its stance to ‘neutral’ from ‘buy’, citing last month’s operational problems. The influential investment bank also upgraded Allegiant Travel (NASDAQ:ALGT), up 3.1%, to ‘buy’ from ‘neutral’, after it posted higher passenger traffic in October.

  • AbbVie (NYSE:ABBV) stock fell 0.2% after a report mentioned the biopharmaceutical company’s Humira rheumatoid arthritis drug as the most extreme case of drugmakers hiking prices without justification in 2020.

  • Quantumscape (NYSE:QS) stock fell 5.6% after Morgan Stanley downgraded its stance on the lithium battery maker to ‘equal weight’ from ‘overweight’, citing potential competition.

  • Lucid Group (NASDAQ:LCID) stock rose 5.1% after the electric vehicle manufacturer reported more than 17,000 reservations for its Lucid Air car, up from 13,000 in the prior quarter. 

  • Royalty Pharma (NASDAQ:RPRX) stock rose 7.9% on the back of news that Berkshire Hathaway has taken a new $475 million stake in the drug royalty purchaser.

  • Peloton (NASDAQ:PTON) stock fell 1% after the fitness equipment maker announced plans to sell an additional $1 billion of its shares, trying to come up with cash amid slowing momentum for its product.
  • DraftKings (NASDAQ:DKNG) stock rose 0.9% after the gambling company's chairman bought 435,000 shares, suggesting confidence in its future.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.